
|Articles|August 1, 2004
- Volume 0 0
Exciting New Advances in Lipid Management: Report from the Annual ACC, ADA and AGS Meetings
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
ADA 2026: Survodutide Cuts Visceral Fat and Normalizes Liver Fat in MASLD. Here's What the Data Mean for Metabolic Risk
2
The Hidden Reimbursement Crisis in Medicare’s Drug Price Negotiation Program
3
ADA 2026: Optimized Inhaled Insulin Dosing Outperforms Subcutaneous Analogs for Postprandial Glucose in T1D
4
FDA Grants Breakthrough Therapy Designation to Investigational Cannabis-Derived Therapy for Chronic Low Back Pain
5






































































































































